Skip to main content

Diagnostic options · UAE

Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 226–240 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3533
SULT2B1 Gene Polycystic Ovary Syndrome Type 1 Genetic Test

This genetic test identifies pathogenic variants within the SULT2B1 gene associated with Polycystic Ovary Syndrome Type 1.

Peripheral Blood (FTA Card or Venous) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SULT2B1 gene", "Steroid sulfation pathway disruption"]
Parameters
[]
Preparation
["No fasting required", "Provide complete clinical history", "Genetic counseling session required"]
Indications
["Diagnosis of PCOS Type 1", "Risk assessment for PCOS Type 1", "Family history of PCOS"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82610-3 ICD-10: E28.2
Clinical summary
This genetic test identifies pathogenic variants within the SULT2B1 gene associated with Polycystic Ovary Syndrome Type 1.
TEST-2873
TBX1 Gene DiGeorge Syndrome Genetic Test

This test evaluates the TBX1 gene for pathogenic variants associated with DiGeorge syndrome.

Peripheral Whole Blood (3–5 mL in EDTA tube); also accepts extracted genomic DNA (≥1 µg) or FTA card blood spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants in TBX1", "Small insertions and deletions in TBX1", "Copy number alterations in TBX1 at exon-level resolution"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Individuals with clinical features suggestive of DiGeorge syndrome", "Family history of DiGeorge syndrome", "Confirmation of diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93936-1 ICD-10: D82.1
Clinical summary
This test evaluates the TBX1 gene for pathogenic variants associated with DiGeorge syndrome.
TEST-1088
TBX5 Full-Length Gene Sequence Analysis (Holt-Oram Syndrome) Test

This test analyzes the entire coding region of the TBX5 gene to identify mutations associated with Holt-Oram syndrome.

Peripheral Blood or Prenatal Specimen (Amniotic Fluid, Chorionic Villi, Cord Blood) 4–6 weeks 5,000.00 AED
View
View test specifications and preparation
What it measures
["TBX5 gene sequence", "Pathogenic variants in TBX5"]
Parameters
[]
Preparation
[]
Indications
["Individuals with clinical features suggestive of Holt-Oram syndrome", "At-risk family members", "Prenatal diagnosis when a familial mutation is known"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77130-7 ICD-10: Q87.2, Z82.79, Z13.79
Clinical summary
This test analyzes the entire coding region of the TBX5 gene to identify mutations associated with Holt-Oram syndrome.
TEST-5090
TBXAS1 Gene Ghosal Hematodiaphyseal Syndrome Genetic Test

This test analyzes the TBXAS1 gene to detect pathogenic variants associated with Ghosal Hematodiaphyseal Syndrome.

Whole Blood (EDTA) or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBXAS1 gene"]
Parameters
[]
Preparation
["No fasting required", "Detailed family history required during pre-genetic counseling"]
Indications
["Suspected Ghosal Hematodiaphyseal Syndrome", "Family history of GHDD", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91898-8 ICD-10: Q78.8
Clinical summary
This test analyzes the TBXAS1 gene to detect pathogenic variants associated with Ghosal Hematodiaphyseal Syndrome.
TEST-3642
TCTN2 Gene (Meckel Syndrome Type 8) Genetic Test

This genetic test evaluates the TCTN2 gene for pathogenic variants associated with Meckel syndrome type 8.

Peripheral Blood (Whole Blood) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TCTN2 gene", "SNVs, indels, CNVs"]
Parameters
[]
Preparation
[]
Indications
["Suspected Meckel syndrome type 8", "Family history of Meckel syndrome type 8", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q87.8
Clinical summary
This genetic test evaluates the TCTN2 gene for pathogenic variants associated with Meckel syndrome type 8.
TEST-5200
TERT Gene Dyskeratosis Congenita Genetic Test

This genetic test evaluates the TERT gene for mutations associated with Dyskeratosis Congenita, a disorder affecting telomere maintenance.

Whole Blood (EDTA), FTA card, or extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TERT gene mutations (point mutations, small insertions/deletions, copy number variations)"]
Parameters
[]
Preparation
["Fasting for 8–12 hours is advised only if a concurrent metabolic panel is ordered.", "Provide a complete medication list to the genetic counselor.", "Parental/guardian consent required for minors."]
Indications
["Suspected Dyskeratosis Congenita", "Diagnosis of telomere biology disorders", "Guiding cancer surveillance", "Family planning in affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: Q82.8, D61.09
Clinical summary
This genetic test evaluates the TERT gene for mutations associated with Dyskeratosis Congenita, a disorder affecting telomere maintenance.
TEST-4624
TERT Gene Sequencing (NGS) for Pulmonary Fibrosis & Bone Marrow Failure Telomeropathy Test

This test analyzes the TERT gene for mutations associated with pulmonary fibrosis and bone marrow failure syndromes.

Peripheral Whole Blood (EDTA tube) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TERT gene pathogenic variants", "Telomere-related disease risk"]
Parameters
[]
Preparation
["Pre-test genetic counseling is mandatory", "No fasting required", "Provide detailed clinical history and family records"]
Indications
["Suspected familial pulmonary fibrosis", "Suspected dyskeratosis congenita", "Suspected aplastic anemia due to telomere dysfunction"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82182-7 ICD-10: J84.112, D61.9, Z15.89
Clinical summary
This test analyzes the TERT gene for mutations associated with pulmonary fibrosis and bone marrow failure syndromes.
TEST-4795
TGFBR1 Gene Sequencing for Marfan Syndrome Test

This test sequences the entire TGFBR1 gene to identify pathogenic variants associated with Marfan syndrome and related connective tissue disorders.

Peripheral whole blood (2 mL EDTA) or buccal swab 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TGFBR1 gene sequence", "Pathogenic variants (SNVs, small indels)"]
Parameters
[]
Preparation
[]
Indications
["Clinical diagnosis or suspicion of Marfan syndrome based on revised Ghent criteria", "First-degree relative with known pathogenic TGFBR1 variant", "Family history of unexplained aortic aneurysm or dissection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81763-4 ICD-10: Q87.40, Z15.89, Z84.81
Clinical summary
This test sequences the entire TGFBR1 gene to identify pathogenic variants associated with Marfan syndrome and related connective tissue disorders.
TEST-4066
TGFBR2 Gene Aortic Aneurysm, Familial Thoracic Type 3 Genetic Test

This test identifies genetic variants in the TGFBR2 gene associated with an increased risk of familial thoracic aortic aneurysm type 3.

Peripheral Whole Blood (5–10 mL) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TGFBR2 gene", "Copy Number Variations (CNV) in the TGFBR2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Individuals with a family history of familial thoracic aortic aneurysm type 3", "Individuals with unexplained aortic root dilation or dissection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81408-6 ICD-10: I71.2
Clinical summary
This test identifies genetic variants in the TGFBR2 gene associated with an increased risk of familial thoracic aortic aneurysm type 3.
TEST-4809
TGFBR2 Gene Genetic Test (Loeys‑Dietz Syndrome Type 2 / Marfanoid Syndromes)

This test evaluates the TGFBR2 gene for mutations associated with Loeys-Dietz syndrome type 2 and related connective tissue disorders.

Whole blood (3-5 mL), extracted DNA (2 µg), or FTA card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TGFBR2 gene sequence", "Copy number variations in TGFBR2", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No medication changes required", "No special preparation needed"]
Indications
["Diagnosis of Loeys-Dietz syndrome type 2", "Diagnosis of related Marfanoid disorders", "Family history of TGFBR2-related conditions", "Unexplained aortic pathology", "Risk assessment for individuals with suspected hereditary connective tissue disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76023-6 ICD-10: Q87.4
Clinical summary
This test evaluates the TGFBR2 gene for mutations associated with Loeys-Dietz syndrome type 2 and related connective tissue disorders.
TEST-4270
THAP1 (DYT6) Gene Sequencing Test (NGS)

This diagnostic test evaluates the THAP1 gene for pathogenic variants associated with early-onset primary dystonia (DYT6). It identifies mutations responsible for this specific mov...

Peripheral Whole Blood (EDTA tube) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the THAP1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"]
Parameters
[{"name": "Analytical Precision", "reference_range": ">99.9% sensitivity & specificity for single nucleotide variants and small indels"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS) with full exon coverage and bioinformatics analysis"}]
Preparation
["No specific fasting required", "Inform the phlebotomist of any medications being taken"]
Indications
["Suspected diagnosis of early-onset primary dystonia (DYT6)", "Family history of DYT6", "Genetic counseling for dystonia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93973-3 ICD-10: G24.1, G24.8
Clinical summary
This diagnostic test evaluates the THAP1 gene for pathogenic variants associated with early-onset primary dystonia (DYT6). It identifies mutations responsible for this specific movement disorder.
TEST-3763
THBD Gene Hemolytic Uremic Syndrome Genetic Test

This test analyzes the THBD gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS). It uses next-generation sequencing (NGS) with copy-number analys...

Whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the THBD gene", "Copy number variations (CNVs) in the THBD gene"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Family cascade screening for THBD variants", "Guiding targeted anti-complement therapies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21683-2 ICD-10: D59.39, Z15.89, N17.9
Clinical summary
This test analyzes the THBD gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS). It uses next-generation sequencing (NGS) with copy-number analysis.
TEST-5595
TSEN54 Gene Pontocerebellar Hypoplasia Type 4 Genetic Test

This genetic test sequences the TSEN54 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 4 (PCH4). It aids in the diagnosis of this severe neurodev...

Peripheral Whole Blood, FTA Card, or Extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TSEN54 gene", "Coding exons ±10 bp intronic boundaries"]
Parameters
[{"name": "Sequencing Depth", "reference_range": "≥100×"}]
Preparation
["No specific fasting required.", "Continue all prescribed medications unless otherwise directed by your physician."]
Indications
["Clinical suspicion of Pontocerebellar Hypoplasia Type 4 (PCH4)", "Family history of PCH4", "Carrier screening for autosomal recessive disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-4 ICD-10: Q04.8
Clinical summary
This genetic test sequences the TSEN54 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 4 (PCH4). It aids in the diagnosis of this severe neurodevelopmental disorder.
TEST-3286
TSR2 Gene Diamond-Blackfan Anemia Type 14 with Mandibulofacial Dysostosis Genetic Test

This test analyzes the TSR2 gene for variants causing Diamond-Blackfan anemia type 14 with mandibulofacial dysostosis.

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TSR2 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variants"]
Parameters
[]
Preparation
["No specific patient preparation required"]
Indications
["Suspected Diamond-Blackfan anemia type 14", "Suspected mandibulofacial dysostosis", "Family history of related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94857-8 ICD-10: D61.0, Q87.0
Clinical summary
This test analyzes the TSR2 gene for variants causing Diamond-Blackfan anemia type 14 with mandibulofacial dysostosis.
TEST-5745
TTBK2 Gene Spinocerebellar Ataxia Type 11, Autosomal Dominant Genetic Test

This genetic test identifies pathogenic variants in the TTBK2 gene associated with autosomal dominant spinocerebellar ataxia type 11 (SCA11). It uses next-generation sequencing (NG...

Whole blood, DNA, or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TTBK2 gene", "Copy number variants (CNVs) in the TTBK2 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected diagnosis of Spinocerebellar Ataxia Type 11 (SCA11)", "Family history of SCA11", "Differential diagnosis of cerebellar ataxia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95134-8 ICD-10: G11.2
Clinical summary
This genetic test identifies pathogenic variants in the TTBK2 gene associated with autosomal dominant spinocerebellar ataxia type 11 (SCA11). It uses next-generation sequencing (NGS) for comprehensive analysis.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.